Baseline Productions

Baseline Productions Accounts Payable

The Accounts Payable of Baseline Productions (BSSP) as of Nov 15, 2026 is 190,800.00 USD. In the previous year, Accounts Payable was 190,800.00 USD — a change of 0.00% (lower).

Accounts Payable

190,800.00USD

YoY

0.00%

Last updated:

Accounts Payable of Baseline Productions is 2020 190,800.00 USD. Accounts Payable of Baseline Productions was 2019 190,800.00 USD. It decreases by 0.00% lower compared to the previous year.

The Baseline Productions Accounts Payable history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Accounts Payable
Date
Accounts Payable
Jan 1, 2014
8,739.00 USD
Jan 1, 2019
190,800.00 USD
Jan 1, 2020
190,800.00 USD
The Baseline Productions Accounts Payable history
YEARAccounts PayableYoY
190,800.00USD0.00%
190,800.00USD+2,083.32%
8,739.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baseline Productions Stock analysis

What does Baseline Productions do? Baseline Productions Inc develops mobile based hardware and software based products. The company focuses on commercialization of its proteins for cancer and infectious disease treatments. Its Irreversible Pepsin Fraction (IPF) technology activates the immune system to fight autoimmune diseases. IPF binds to T-cells and triggers Th1 responses that eliminate infected cells. The firm's lead compound is an IPF suspension for autoimmune disease treatment including cancer, cirrhosis, and Hepatitis C. The product IMMUNE-THERAPEUTIC PROTEIN (ITP) is a therapeutic protein derived from porcine pepsin, which is irreversible, modified, and fractionated to IPF sequence. The company sells its IPF platform technology and ITP product to healthcare providers and pharmaceutical companies. Healthcare providers use IPF for immune system activation in autoimmune disease treatment. Pharmaceutical companies purchase ITP for development into therapeutic applications. The target segments include medical institutions treating autoimmune conditions and drug manufacturers seeking novel protein-based therapies. ITP is specifically indicated for cancer, cirrhosis, and Hepatitis C treatment. Baseline Productions generates revenue through licensing IPF technology and selling ITP therapeutic protein. The IPF platform is sold as a technology solution to partners in the healthcare sector. ITP is marketed as a therapeutic product for direct sale to medical facilities. The company's primary customers are healthcare institutions and pharmaceutical firms interested in immune system-based treatments for autoimmune diseases and infectious conditions. Baseline Productions is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baseline Productions stock

Accounts Payable of Baseline Productions is 190,800.00 USD in 2020.

Accounts Payable of Baseline Productions changed from 190,800.00 USD to 190,800.00 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Payable Baseline Productions since 2006 – with annual values, charts, and detailed analysis.

Accounts payable represents money owed to suppliers for goods and services received. It is a key component of working capital management.

Accounts Payable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Payable's Baseline Productions historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Baseline Productions

All Key Metrics — Baseline Productions